Published on February 23, 2021Citation: Kim DD, Do LA, Daly AT, Wong JB, Chambers JD, Ollendorf DA, Neumann PJ. An Evidence Review of Low-Value Care Recommendations: Inconsistency and Lack of Economic Evidence Considered. J Gen Intern Med. 2021 Feb 23.Journal: Journal Of General Internal MedicineRead Publication
Published on January 30, 2021Citation: Olchanski N, van Klaveren D, Cohen JT, Wong JB, Ruthazer R, Kent DM. Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained. Acta Diabetologica 2021.Journal: Acta DiabetologicaRead Publication
Published on January 13, 2021Citation: Mulé CM, Lavelle TA, Sliwinski SK, Wong JB. Shared Decision-Making During Initial Diagnostic and Treatment Planning Visits for Children with Autism Spectrum Disorder. Journal of Developmental & Behavioral Pediatrics 2021.Journal: Journal of Developmental and Behavioral PediatricsRead Publication
Published on December 2, 2020Citation: Neumann PJ, Chambers JD. "Eroding progress on evidence and outcomes: CMS’s new proposed pathway for medical device coverage," Health Affairs Blog, December 2, 2020.Journal: Health Affairs blogRead Publication
Published on December 2, 2020Citation: Basu A, Neumann PJ, Sullivan S. "International reference pricing: A lazy, misguided, bi-partisan plan to lower US drug prices," Health Affairs Blog, December 2, 2020.Journal: Health Affairs blogRead Publication
Published on November 19, 2020Citation: Neumann PJ, Cohen JT, Kim DD, Ollendorf DA. Consideration of value-based pricing for treatments and vaccines is important, even in the COVID-19 pandemic. Health Affairs 2020;40(1):53–61.Journal: Health AffairsRead Publication
Published on August 18, 2020Citation: Lin, PJ, Cohen, JT, Neumann, PJ. Preparing the health‐care system to pay for new Alzheimer's drugs. Alzheimer's Dement. 2020; 1– 3.Journal: Alzheimer's & DementiaRead Publication
Published on July 27, 2020Citation: Ma S, Kim DD, Cohen JT, Neumann PJ. "Measuring “fearonomic effects” in valuing therapies: An application to COVID-19 in China," Value in Health (in press). Journal: Value in HealthRead Publication
Published on July 22, 2020Citation: Kim, DD, Silver, MC, Kunst, N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and costing in cost-effectiveness analysis, 1974–2018. PharmacoEconomics 38, 1135–1145 (2020).Journal: PharmacoEconomics Read Publication
Published on July 17, 2020Citation: Kim DD, Ollendorf DA, Neumann PJ, Fendrick M. "Crisis into opportunity: Can COVID-19 help set a path to improved health care efficiency?,"AJMC Commentary, June 17, 2020. Journal: American Journal of Managed CareRead Publication
